AI assistant
Sending…
EXACT SCIENCES CORP — Director's Dealing 2017
Aug 17, 2017
30597_dirs_2017-08-17_3c5a3d08-dbfa-4f14-a0d7-b8c4f0b61cea.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: EXACT SCIENCES CORP (EXAS)
CIK: 0001124140
Period of Report: 2017-08-17
Reporting Person: Conroy Kevin T (Director, President and CEO)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2017-08-17 | Common Stock | M | 9242 | $10.82 | Acquired | 830052 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2017-08-17 | Stock Option (right to buy) | $10.82 | M | 9242 | Disposed | 2023-02-22 | Common Stock (106000) | Direct |
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Stock | 24990 | Indirect |
| Common Stock | 65189 | Indirect |
Footnotes
F1: These options vest and become exercisable in four equal annual installments beginning on February 22, 2014.
More from EXACT SCIENCES CORP
Major Shareholding Notification
2026
Mar 26
Regulatory Filings
2026
Mar 23
Regulatory Filings
2026
Mar 23
Regulatory Filings
2026
Mar 23
Regulatory Filings
2026
Mar 23
Regulatory Filings
2026
Mar 23
Regulatory Filings
2026
Mar 23
Regulatory Filings
2026
Mar 23
Regulatory Filings
2026
Mar 23
Regulatory Filings
2026
Mar 23